AKT1 and hepatocellular carcinoma: Zhang et al. showed that upregulation of cyclin-dependent kinase inhibitors, p21 (Cip1) and p27 (Kip1), enhanced transactivation of FOXO4 factor and dysregulation of AKT signaling associated with inhibition of cell proliferation and tumorigenicity of hepatoma cells [27].